Shares of Onconova Therapeutics Inc. (NASDAQ:ONTX) traded down 0.8% during trading on Tuesday . The company traded as low as $3.78 and last traded at $3.88, with a volume of 346,803 shares traded. The stock had previously closed at $3.91.

Separately, Maxim Group reiterated a “buy” rating and issued a $6.00 target price on shares of Onconova Therapeutics in a report on Friday, August 19th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $24.74.

The stock’s market cap is $22.70 million. The stock’s 50 day moving average price is $4.00 and its 200-day moving average price is $4.71.

Onconova Therapeutics (NASDAQ:ONTX) last announced its earnings results on Monday, August 15th. The biopharmaceutical company reported ($1.96) earnings per share (EPS) for the quarter. The company had revenue of $2.25 million for the quarter. Equities research analysts forecast that Onconova Therapeutics Inc. will post ($7.40) EPS for the current fiscal year.

Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.